Alliancebernstein »

Enliven Therapeutics shares owned by Alliancebernstein

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Alliancebernstein from 13F filings

Historical chart of Alliancebernstein investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Alliancebernstein consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Alliancebernstein

Quarter filed Position value Share count Share price at filing
2023-12-31 $207k 15k 13.84
2023-09-30 $196k 14k 13.66